ALDEYRA THERAPEUTICS, INC. Cash
ALDEYRA THERAPEUTICS, INC. (ALDX) had Cash of $33.37 million as of 2022-06-30, per its 10-Q filed 2022-08-05.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:Cash · last filed 2022-08-05
- 2022-06-30: Cash $33.37M.
- 2022-03-31: Cash $87.56M.
- 2021-12-31: Cash $100.36M.
- 2021-09-30: Cash $111.97M.
| Period end | Cash |
|---|---|
| 2022-06-30 | $33.37M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $87.56M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $100.36M 10-Q · filed 2022-08-05 |
| 2021-09-30 | $111.97M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $120.35M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $84.07M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $23.49M 10-K · filed 2022-03-17 |
| 2020-09-30 | $31.82M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.85M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $7.13M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $15.36M 10-K · filed 2021-03-11 |
| 2019-09-30 | $6.47M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $1.96M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $3.10M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $2.13M 10-K · filed 2020-03-12 |
| 2018-09-30 | $5.91M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $5.43M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.35M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $979.49K 10-K · filed 2019-03-08 |
| 2017-09-30 | $1.04M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.20M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $8.71M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $394.85K 10-K · filed 2017-03-30 |
| 2016-09-30 | $424.61K 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.06M 10-Q · filed 2016-08-10 |
| 2016-03-31 | $1.13M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $1.66M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |